Medicare data was the original source for research on geographic variation in health care utilization, cost and quality. It continues to be a fertile source for such research and at the recent meeting of the Medicare Payment Advisory Commission, staff presented the latest analysis. (MedPAC Presentation) As the analysis initially points out, it is important to separate the effects of service use from price in looking at spending variation; they do not co-vary universally or consistently. Service use variation results from volume and service complexity, as well as health status. Even in Medicare, with its fiat prices, there are price differences depending on regional cost factors and add-on payments. The latest analysis used data from 2013 and 2014. They adjusted for add-on payments, demographics and health status. 484 geographic units were used. Service use is strongly clustered around the national average; spending is more diffuse, especially on the right, or high, side of the distribution. Per capita service use is close to equal in urban and rural areas. A very large proportion of the variation is accounted for by post-acute care–skilled nursing care, home care, etc. The ratio of 90th percentile spending to 10th percentile is 1.88 for post-acute care, 1.16 for inpatient care and 1.2 for ambulatory care. Hence the drive to get bundled payments that include post-acute care. Looking at those fee-for-service beneficiaries with drug coverage, they are more likely to be older, female, high higher spending and more medical conditions. Geographic variation in drug use is less than the variation in drug spending. Drug use is more concentrated among a subset of beneficiaries than is medical spending. There was no systematic relationship between amount of drug use and total use of medical services or large categories of medical care in a particular geographic area. Since the last analysis in 2011, the staff found that variation in medical service use had declined slightly and even post-acute care use variation was lower. Some notable areas with high spending–Miami, McAllen, Texas–had average spending that declined, but was still much higher than the national average.
✅ Subscribe via Email
About this Blog
The Healthy Skeptic is a website about the health care system, and is written by Kevin Roche, who has many years of experience working in the health industry. Mr. Roche is available to assist health care companies through consulting arrangements through Roche Consulting, LLC and may be reached at [email protected].
Healthy Skeptic Podcast
This is an outstanding report on total global drug spending and trends, with projections out to 2025. It helps you understand this important area of health care, which does much...
June 1, 2021
MedPAC 2019 Report to Congress
June 18, 2019
Mental health company Headway makes, well, headway, by raising an impressive $125 million round of new capital. The company connects patients with mental health providers and facilitates providers working with...
October 11, 2023
Two health care firms owned by private equity firms are merging in a transaction supposedly valued at $3 billion. HealthComp administers self-funded plans for employers and other groups and Virgin...
September 27, 2023
NextGen, an electronic medical records firm, is being put out of its public company misery, as a PE firm will pay $1.6 billion for the one-time high-flier.
September 7, 2023
Access ACO Care Management Chronic Disease Comparative Effectiveness Consumer Directed Health Consumers Devices Disease Management Drugs EHRs Elder Care End-of-Life Care FDA Financings Genomics Government Health Care Costs Health Care Quality Health Care Reform Health Insurance Health Insurance Exchange HIT HomeCare Hospital Hospital Readmissions Legislation M&A Malpractice Meaningful Use Medicaid Medical Care Medicare Medicare Advantage Mobile Pay For Performance Pharmaceutical Physicians Providers Regulation Repealing Reform Telehealth Telemedicine Wellness and Prevention Workplace